Towards understanding and treatment of MeCP2-related disorders

Bird, Adrian (Principal Investigator)

Status	Finished
Effective start/end date	1/01/16 → 30/06/22

Funding

UK-based charities: £2,996,065.00

21 Article
1 Review article

MeCP2 binds to methylated DNA independently of phase separation and heterochromatin organisation
Pantier, R., Brown, M., Han, S., Paton, K., Meek, S., Montavon, T., Shukeir, N., Mchugh, T., Kelly, D., Hochepied, T., Libert, C., Jenuwein, T., Burdon, T. & Bird, A. P., 8 May 2024, In: Nature Communications. 15, 1, p. 1-14 14 p., 3880.
Research output: Contribution to journal › Article › peer-review

Open Access
File
A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assay
Alexander-Howden, B., Zhang, L., van der Sloot, A. M., Tollis, S., St-Cyr, D. J., Sicheri, F., Bird, A. P., Tyers, M. & Lyst, M. J., 8 Mar 2023, In: Scientific Reports. 13, 1, 10 p., 3868.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Structure of SALL4 zinc-finger domain reveals link between AT-rich DNA binding and Okihiro syndrome
Watson, J., Pantier, R., Jayachandran, U., Chhatbar, K., Alexander-Howden, B., Kruusvee, V., Prendecki, M., Bird, A. P. & Cook, A. G., Mar 2023, In: Life Science Alliance. 6, 3, 13 p., e202201588.
Research output: Contribution to journal › Article › peer-review

Open Access
File